Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora

被引:61
作者
Richard, P
Delangle, MH
Raffi, F
Espaze, E
Richet, H
机构
[1] Hop Hotel Dieu, Lab Bacteriol Virol Hyg Hosp, Nantes, France
[2] Hop Hotel Dieu, Serv Med Interne B, Nantes, France
关键词
D O I
10.1086/317551
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We assessed the risk factors for acquisition of fluoroquinolone-resistant, gram-negative organisms in the gastrointestinal tract of hospitalized patients. We analyzed stool samples from 204 patients and recovered fluoroquinolone-resistant, gram-negative organisms from 63. Receipt of fluoroquinolone during the month preceding admission was the only risk factor identified, whereas female sex, duration of hospitalization, exposure to indwelling devices, admission from another hospital, and history of infection were risk factors for fecal colonization after day 4.
引用
收藏
页码:162 / 166
页数:5
相关论文
共 30 条
[1]  
ANDREMONT A, 1981, ANN INST PASTEUR MIC, VB132, P419
[2]   PHARMACOKINETICS OF CIPROFLOXACIN AND EFFECT OF REPEATED DOSAGE ON SALIVARY AND FECAL MICROFLORA [J].
BERGAN, T ;
DELIN, C ;
JOHANSEN, S ;
KOLSTAD, IM ;
NORD, CE ;
THORSTEINSSON, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) :298-302
[3]   CHANGES IN THE PHARMACOKINETICS OF CIPROFLOXACIN AND FECAL FLORA DURING ADMINISTRATION OF A 7-DAY COURSE TO HUMAN VOLUNTEERS [J].
BRUMFITT, W ;
FRANKLIN, I ;
GRADY, D ;
HAMILTONMILLER, JMT ;
ILIFFE, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :757-761
[4]   A nosocomial outbreak due to Enterobacter cloacae strains with the E-hormaechei genotype in patients treated with fluoroquinolones [J].
DavinRegli, A ;
Bosi, C ;
Charrel, R ;
Ageron, E ;
Papazian, L ;
Grimont, PAD ;
Cremieux, A ;
Bollet, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (04) :1008-1010
[5]   RAPID EMERGENCE OF QUINOLONE RESISTANCE IN CIRRHOTIC-PATIENTS TREATED WITH NORFLOXACIN TO PREVENT SPONTANEOUS BACTERIAL PERITONITIS [J].
DUPEYRON, C ;
MANGENEY, N ;
SEDRATI, L ;
CAMPILLO, B ;
FOUET, P ;
LELUAN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :340-344
[6]   EFFECT OF NORFLOXACIN ON HUMAN OROPHARYNGEAL AND COLONIC MICROFLORA AND MULTIPLE-DOSE PHARMACOKINETICS [J].
EDLUND, C ;
BERGAN, T ;
JOSEFSSON, K ;
SOLBERG, R ;
NORD, CE .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1987, 19 (01) :113-121
[7]  
EDLUND C, 1988, SCAND J INFECT DIS, P14
[8]   A REVIEW ON THE IMPACT OF 4-QUINOLONES ON THE NORMAL OROPHARYNGEAL AND INTESTINAL HUMAN MICROFLORA [J].
EDLUND, C ;
NORD, CE .
INFECTION, 1988, 16 (01) :8-12
[9]   IMPACT OF ORAL CIPROFLOXACIN ON THE FECAL FLORA OF HEALTHY-VOLUNTEERS [J].
ENZENSBERGER, R ;
SHAH, PM ;
KNOTHE, H .
INFECTION, 1985, 13 (06) :273-275
[10]   Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: The emergence of decreased susceptibility to the fluoroquinolones [J].
Fox, KK ;
Knapp, JS ;
Holmes, KK ;
Hook, EW ;
Judson, FN ;
Thompson, SE ;
Washington, JA ;
Whittington, WL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (06) :1396-1403